Mitral Valve

The heart's mitral valve is the site of the most surgical valve repairs and valve replacements. After the resounding success of transcatheter aortic valve replacement (TAVR), which now makes up more than 50% of aortic valve replacements, there is wide expectation transcatheter mitral replacements will follow in the next few year. Currently, the most common transcatheter mitral procedure is transcatheter edge-to-edge (TEER) , using the MitraClip or Pascal clip devices. These devices are also being used for transcatheter tricuspid valve repair (TTVR). Other transcatheter mitral repair systems are in trials for minimally invasive annuloplasty and chordae tendineae repair. 

RSS icon
calculation

New risk calculator detects TEER patients who may need to be readmitted for HF

Once the tool's performance is properly validated, it could help clinicians deliver better patient care and result in significant cost savings for health systems.

November 12, 2021

TMVR with transfemoral access a 'promising option,’ early data suggest

Researchers reported at TCT 2021 that survival was 100% after 30 days.

November 8, 2021
Doctor patient

Two-year outcomes highlight the value of TMVR for patients with severe MR

Patients continue to see the benefits of transcatheter mitral valve replacement a full two years after treatment.

November 2, 2021

Mitral valve prolapse during pregnancy linked to higher risk of cardiac complications

MVP also appears to increase the risk of certain problems during childbirth. 

October 25, 2021
Old doctor

TEER associated with ‘important and significant’ reductions in hospitalization rates

Considering the study's high-risk patient population, researchers were especially impressed by these one-year outcomes.

October 22, 2021
surgery.jpg

CUTTING-EDGE findings shine new light on mitral valve surgery after failed TEER

Overall, mitral valve surgery after TEER was associated with a 30-day mortality rate of 16.6% and one-year mortality rate of 31.3%.

October 8, 2021

TEER benefits all HF patients with SMR, but men see more long-term benefits

The study's authors examined data from men and women who underwent TEER with the MitraClip device in addition to guideline-directed medical therapy. 

September 22, 2021

Valve-in-valve TMVR an effective option for patients with mitral prosthesis dysfunction

Adjusted mortality and perioperative complications were both lower among patients undergoing ViV TMVR.

September 8, 2021
Displaying 57 - 64 of 89
Design by Adaptive Theme